Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China
· Delayed Price · Currency is CNY 10.85
0.00 (0.00%)
Mar 10, 2026, 9:35 AM CST
SHA:600420 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 1,084 | 691.88 | 627.79 | 568.28 | Upgrade
|
| Depreciation & Amortization | - | 766.23 | 818.89 | 842.49 | 820.27 | Upgrade
|
| Other Amortization | - | 12.07 | 6.36 | 6.06 | 10.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 31.31 | 31.85 | 1.1 | -0.2 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 28.26 | 13.13 | 3.43 | 135.66 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -64.11 | -27.45 | -2.34 | 24.04 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -2.36 | -18.05 | -17.59 | 24.87 | Upgrade
|
| Other Operating Activities | - | 427.46 | 399.15 | 393.7 | 405.67 | Upgrade
|
| Change in Accounts Receivable | - | 732.85 | 485.43 | 463.12 | -921.35 | Upgrade
|
| Change in Inventory | - | 60.54 | 163.27 | 625.24 | 195.31 | Upgrade
|
| Change in Accounts Payable | - | -918.52 | -832.62 | -30.39 | 444.18 | Upgrade
|
| Operating Cash Flow | - | 2,256 | 1,720 | 2,856 | 1,680 | Upgrade
|
| Operating Cash Flow Growth | - | 31.13% | -39.76% | 70.01% | 7.66% | Upgrade
|
| Capital Expenditures | - | -219.77 | -357.19 | -307.44 | -521.44 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 21.95 | 10.96 | 5 | 3.72 | Upgrade
|
| Investment in Securities | - | 3 | 2.01 | - | 1.14 | Upgrade
|
| Other Investing Activities | - | -661.4 | -1,019 | - | 8.31 | Upgrade
|
| Investing Cash Flow | - | -856.23 | -1,363 | -302.44 | -508.28 | Upgrade
|
| Long-Term Debt Issued | - | 50 | 45 | 2,346 | 3,685 | Upgrade
|
| Total Debt Issued | - | 50 | 45 | 2,346 | 3,685 | Upgrade
|
| Long-Term Debt Repaid | - | -61.44 | -774.23 | -3,203 | -3,402 | Upgrade
|
| Total Debt Repaid | - | -61.44 | -774.23 | -3,203 | -3,402 | Upgrade
|
| Net Debt Issued (Repaid) | - | -11.44 | -729.23 | -856.83 | 282.87 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,188 | - | Upgrade
|
| Common Dividends Paid | - | -300.68 | -189.35 | -184.7 | -212.46 | Upgrade
|
| Other Financing Activities | - | -103.3 | -174.8 | -581.78 | -732.81 | Upgrade
|
| Financing Cash Flow | - | -415.42 | -1,093 | -435.32 | -662.41 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 29.63 | 32.07 | 94.24 | -40.08 | Upgrade
|
| Net Cash Flow | - | 1,014 | -703.83 | 2,212 | 468.9 | Upgrade
|
| Free Cash Flow | - | 2,036 | 1,363 | 2,548 | 1,158 | Upgrade
|
| Free Cash Flow Growth | - | 49.37% | -46.50% | 120.01% | -2.03% | Upgrade
|
| Free Cash Flow Margin | - | 18.62% | 11.29% | 19.66% | 8.31% | Upgrade
|
| Free Cash Flow Per Share | - | 1.52 | 1.07 | 2.20 | 0.98 | Upgrade
|
| Cash Income Tax Paid | - | 693.04 | 751.63 | 617.65 | 696.29 | Upgrade
|
| Levered Free Cash Flow | - | 1,668 | 1,796 | 1,634 | 621.88 | Upgrade
|
| Unlevered Free Cash Flow | - | 1,691 | 1,832 | 1,701 | 690.92 | Upgrade
|
| Change in Working Capital | - | -26.52 | -195.37 | 1,001 | -309.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.